Treatment of Sickle Cell Anemia with Hydroxyurea and ErythropoietinMark A. Goldberg, H. Franklin Bunn, Samuel Charache et al.|New England Journal of Medicine|1990Cited by 202
Correction of the Nonlinear Dose Response Improves the Viability of Adenoviral Vectors for Gene Therapy of Fabry DiseaseRobin J. Ziegler, Seng H. Cheng, Chester Li et al.|Human Gene Therapy|2002Cited by 46